Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Home
About
Our Commitment
Our Leadership
Our Facilities
Science
Our Discovery
Our Target
Our Publications
Platform
BDDS™ Platform
Core Technologies
Nanomedicine in Action
Pipeline
Our Programs
Our Focus Areas
Investors
News
Careers
KR
EN
KR
Home
»
Our Publications
SCIENCE
Our Publications
ALL
AD
AD Biomarker
mRNA Vaccine
Diagnosis
Filter
AD
AD Biomarker
Diagnosis
mRNA Vaccine
AD
The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer’s disease
July 13, 2023
Objectives Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive long-term memory loss…
AD
The role of microRNA-485 in neurodegenerative disease
July 7, 2022
Neurodegenerative diseases (NDDs) are age-related disorders characterized by progressive neurodegeneration and neuronal cell loss in…
AD Biomarker
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
December 4, 2021
1. BIORCHESTRA Co., Ltd., 17, Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea 2. Department of Infection…
AD
Innate Immunity and Cell Death in Alzheimer’s Disease
October 20, 2021
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cytokines…
AD Biomarker
MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics
September 14, 2021
Chang Youn Lee1, Jin Hyeob Ryu1* and Hyun Jeong Cho2* Biorchestra Co. Ltd., Techno 4-ro,…
mRNA Vaccine
Influenza Viruses: Innate Immunity and mRNA Vaccines
August 31, 2021
Front. Immunol., 31 August 2021 Sec. Vaccines and Molecular Therapeutics View Publication
AD Biomarker
miRNAs as Therapeutic Tools in Alzheimer’s Disease
May 28, 2021
1. BIORCHESTRA Co., Ltd., Techno4-ro 17, Daejeon 34013, Korea 2. Department of Biomedical Laboratory Science,…
Diagnosis
Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets
December 12, 2020
2020 Dec;42(12):1467-1475. doi: 10.1007/s13258-020-01015-6. Epub 2020 Nov 12. View Publication
Filter
AD
AD
The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer’s disease
July 13, 2023
Objectives Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive long-term memory loss…
AD
The role of microRNA-485 in neurodegenerative disease
July 7, 2022
Neurodegenerative diseases (NDDs) are age-related disorders characterized by progressive neurodegeneration and neuronal cell loss in…
AD
Innate Immunity and Cell Death in Alzheimer’s Disease
October 20, 2021
The innate immune system plays key roles in controlling Alzheimer's disease (AD), while secreting cytokines…
Filter
AD Biomarker
AD Biomarker
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
December 4, 2021
1. BIORCHESTRA Co., Ltd., 17, Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea 2. Department of Infection…
AD Biomarker
MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics
September 14, 2021
Chang Youn Lee1, Jin Hyeob Ryu1* and Hyun Jeong Cho2* Biorchestra Co. Ltd., Techno 4-ro,…
AD Biomarker
miRNAs as Therapeutic Tools in Alzheimer’s Disease
May 28, 2021
1. BIORCHESTRA Co., Ltd., Techno4-ro 17, Daejeon 34013, Korea 2. Department of Biomedical Laboratory Science,…
Filter
mRNA Vaccine
mRNA Vaccine
Influenza Viruses: Innate Immunity and mRNA Vaccines
August 31, 2021
Front. Immunol., 31 August 2021 Sec. Vaccines and Molecular Therapeutics View Publication
Filter
Diagnosis
Diagnosis
Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets
December 12, 2020
2020 Dec;42(12):1467-1475. doi: 10.1007/s13258-020-01015-6. Epub 2020 Nov 12. View Publication
Close Menu
Home
About
Our Commitment
Our Leadership
Our Facilities
Science
Our Discovery
Our Target
Our Publications
Platform
BDDS™ Platform
Core Technologies
Nanomedicine in Action
Pipeline
Our Programs
Our Focus Areas
Investors
News
Careers
BIORCHESTRA Global
KR
EN
KR
© 2023 BIORCHESTRA Co., Ltd. All Rights Reserved